¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Ä¡·áº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Estrogen Receptor Positive Breast Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Targeted Therapy), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1553538
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀåÀº 2030³â±îÁö 337¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.89% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀå¿¡´Â ÀÌ ¾ÆÇü À¯¹æ¾ÏÀ» Ç¥ÀûÈ­ÇÏ°í °ü¸®Çϱâ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ´Ù¾çÇÑ Ä¡·á ¿É¼ÇÀÌ Æ÷ÇԵ˴ϴÙ.

¾à¹° °³¹ßÀÇ Çõ½ÅÀº ER À¯¹æ¾Ï Ä¡·á ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. »õ·Î¿î Ä¡·á¹ý¿¡´Â »õ·Î¿î ¾Æ·Î¸¶Å¸Á¦ ¾ïÁ¦Á¦, ¼±ÅÃÀû ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ºÐÇØÁ¦(SERD), Ç¥ÀûÄ¡·áÁ¦ µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù FDA´Â ESR1 º¯À̰¡ ÀÖ´Â ÀüÀ̼º ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º, HER2 À½¼º À¯¹æ¾Ï¿¡ ´ëÇÑ °æ±¸¿ë 󹿾àÀÎ ¿À¼¿µà¸¦ ½ÂÀÎÇÏ¿© °³ÀÎ ¸ÂÃãÇü Ä¡·á Àü·«À¸·ÎÀÇ ÀüȯÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

Á¦¾à»ç, »ý¸í°øÇÐ ±â¾÷, ¿¬±¸±â°üÀÇ Àü·«Àû Á¦ÈÞ ¹× Çù·Â °ü°è´Â ER À¯¹æ¾Ï Ä¡·á ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù ¸Þ³ª¸®´Ï ±×·ìÀÌ ÀνǸ®ÄÚ ¸Þµð½Å°ú ½Å±Ô KAT6A ¾ïÁ¦Á¦ °³¹ß¿¡ ´ëÇÑ ¶óÀ̼±½º °è¾àÀ» ü°áÇÑ °ÍÀº ¾Ï Ä¡·á Æ®·»µå¸¦ ¹ßÀü½Ã۱â À§ÇÑ °øµ¿ ³ë·ÂÀÇ Ãß¼¼¸¦ °­Á¶ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÆÄÆ®³Ê½ÊÀº Á¾Á¾ ¾à¹° °³¹ßÀÇ °¡¼ÓÈ­¿Í º¸´Ù Á¾ÇÕÀûÀÎ Ä¡·á ¿É¼ÇÀ¸·Î À̾îÁ® Àüü ER À¯¹æ¾Ï Ä¡·á ȯ°æÀ» °­È­ÇÏ°í ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå : Ä¡·áº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ¾ç¼º À¯¹æ¾Ï Ä¡·á ½ÃÀå : Ä¡·á ¹× ÃÖÁ¾ ¿ëµµº° Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Estrogen Receptor Positive Breast Cancer Treatment Market Growth & Trends:

The global estrogen receptor positive breast cancer treatment market is anticipated to reach USD 33.7 billion by 2030 and is projected to grow at a CAGR of 7.89% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market includes a variety of therapeutic options specifically designed to target and manage this subtype of breast cancer.

Innovations in drug development are significantly impacting the ER+ breast cancer treatment market. New therapies include novel aromatase inhibitors, selective estrogen receptor degraders (SERDs), and targeted treatments. For instance, in January 2023, the FDA authorized Orserdu, an oral prescription for metastatic estrogen receptor-positive, HER2-negative breast cancer with an ESR1 mutation, underscoring a shift towards personalized treatment strategies.

Strategic collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions significantly impact the market for ER+ breast cancer treatment. For instance, in June 2024, Menarini Group's licensing agreement with Insilico Medicine to develop a new KAT6A inhibitor underscores the trend toward collaborative efforts to advance oncology treatments. These partnerships often lead to accelerated drug development and more comprehensive treatment options, enhancing the overall treatment landscape for ER+ breast cancer and contributing to market expansion.

Estrogen Receptor Positive Breast Cancer Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Estrogen Receptor Positive Breast Cancer Treatment Market Variables, Trends & Scope

Chapter 4. Estrogen Receptor Positive Breast Cancer Treatment Market: Treatment Estimates & Trend Analysis

Chapter 5. Estrogen Receptor Positive Breast Cancer Treatment Market: End Use Estimates & Trend Analysis

Chapter 6. Estrogen Receptor Positive Breast Cancer Treatment Market: Regional Estimates & Trend Analysis by Treatment, and End Use

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â